0001209191-19-008514.txt : 20190208 0001209191-19-008514.hdr.sgml : 20190208 20190208162552 ACCESSION NUMBER: 0001209191-19-008514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190206 FILED AS OF DATE: 20190208 DATE AS OF CHANGE: 20190208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Mina CENTRAL INDEX KEY: 0001668163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36548 FILM NUMBER: 19580212 MAIL ADDRESS: STREET 1: C/O SUNRUN INC. STREET 2: 595 MARKET STREET, 29TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001604464 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 460920988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-278-8930 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-06 0 0001604464 Atara Biotherapeutics, Inc. ATRA 0001668163 Kim Mina C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Senior VP & General Counsel Common Stock 2019-02-06 4 A 0 17063 0.00 A 60063 D Employee Stock Option (Right to Buy) 38.47 2019-02-06 4 A 0 34125 0.00 A 2029-02-05 Common Stock 34125 34125 D These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service. Includes 500 shares purchased on November 30, 2018 pursuant to the Issuer's Employee Stock Purchase Plan. 1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2019, subject to the reporting person's continuous service.. /s/ David Tucker, Attorney-in-Fact for Mina Kim 2019-02-08